Treatment of Cerebral Vasospasm Following Aneurysmal Subarachnoid Hemorrhage using the Neurospeed Semi-compliant Balloon.
Aneurysm
Angioplasty
Delayed cerebral ischemia
Medical device
Stroke
Journal
Clinical neuroradiology
ISSN: 1869-1447
Titre abrégé: Clin Neuroradiol
Pays: Germany
ID NLM: 101526693
Informations de publication
Date de publication:
22 Feb 2024
22 Feb 2024
Historique:
received:
23
10
2023
accepted:
18
01
2024
medline:
22
2
2024
pubmed:
22
2
2024
entrez:
22
2
2024
Statut:
aheadofprint
Résumé
Cerebral vasospasm (CV) following aneurysmal subarachnoid hemorrhage (aSAH) may lead to morbidity and mortality. Endovascular mechanical angioplasty may be performed if symptomatic CV is refractory to noninvasive medical management. Off-label compliant remodelling balloons tend to conform to the course of the vessel, contrary to noncompliant or semi-compliant balloons. Our objective is to describe our initial experience with the semi-compliant Neurospeed balloon (approved for intracranial stenosis) in cerebral vasospasm treatment following aSAH. All patients included in the prospective observational SAVEBRAIN PWI (NCT05276934 on clinicaltrial.gov) study who underwent cerebral angioplasty using the Neurospeed balloon for the treatment of medically refractory and symptomatic CV after aSAH were identified. Patient demographic information, procedural details and outcomes were obtained from electronic medical records. Between February 2022 and June 2023, 8 consecutive patients underwent CV treatment with the Neurospeed balloon. Angioplasty of 48 arterial segments (supraclinoid internal carotid artery, A1 and A2 segments of the anterior cerebral artery, M1 and M2 segments of the middle cerebral artery) was attempted and 44/48 (92%) were performed. The vessel diameter significantly improved following angioplasty (+81%), while brain hypoperfusion decreased (-81% of the mean TMax). There was no long-term clinical complication, 4% periprocedural complications occurred. The semi-compliant Neurospeed balloon is effective in the treatment of cerebral vasospasm following aSAH, bringing a new device into the armamentarium of the neurointerventionalist to perform intracranial angioplasty.
Sections du résumé
BACKGROUND AND PURPOSE
OBJECTIVE
Cerebral vasospasm (CV) following aneurysmal subarachnoid hemorrhage (aSAH) may lead to morbidity and mortality. Endovascular mechanical angioplasty may be performed if symptomatic CV is refractory to noninvasive medical management. Off-label compliant remodelling balloons tend to conform to the course of the vessel, contrary to noncompliant or semi-compliant balloons. Our objective is to describe our initial experience with the semi-compliant Neurospeed balloon (approved for intracranial stenosis) in cerebral vasospasm treatment following aSAH.
METHODS
METHODS
All patients included in the prospective observational SAVEBRAIN PWI (NCT05276934 on clinicaltrial.gov) study who underwent cerebral angioplasty using the Neurospeed balloon for the treatment of medically refractory and symptomatic CV after aSAH were identified. Patient demographic information, procedural details and outcomes were obtained from electronic medical records.
RESULTS
RESULTS
Between February 2022 and June 2023, 8 consecutive patients underwent CV treatment with the Neurospeed balloon. Angioplasty of 48 arterial segments (supraclinoid internal carotid artery, A1 and A2 segments of the anterior cerebral artery, M1 and M2 segments of the middle cerebral artery) was attempted and 44/48 (92%) were performed. The vessel diameter significantly improved following angioplasty (+81%), while brain hypoperfusion decreased (-81% of the mean TMax). There was no long-term clinical complication, 4% periprocedural complications occurred.
CONCLUSION
CONCLUSIONS
The semi-compliant Neurospeed balloon is effective in the treatment of cerebral vasospasm following aSAH, bringing a new device into the armamentarium of the neurointerventionalist to perform intracranial angioplasty.
Identifiants
pubmed: 38386051
doi: 10.1007/s00062-024-01390-7
pii: 10.1007/s00062-024-01390-7
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
Références
Lovelock CE, Rinkel GJ, Rothwell PM. Time trends in outcome of subarachnoid hemorrhage: Population-based study and systematic review. Neurology. 2010;74(19):1494–501. https://doi.org/10.1212/WNL.0b013e3181dd42b3 .
Rivero-Arias O, Gray A, Wolstenholme J. Burden of disease and costs of aneurysmal subarachnoid haemorrhage (aSAH) in the United Kingdom. Cost Eff Resour Alloc. 2010;8:6. https://doi.org/10.1186/1478-7547-8-6 .
doi: 10.1186/1478-7547-8-6
pubmed: 20423472
pmcid: 2874525
Rehman S, Phan HT, Reeves MJ, Thrift AG, Cadilhac DA, Sturm J et al. Case-Fatality and Functional Outcome after Subarachnoid Hemorrhage (SAH) in INternational STRoke oUtComes sTudy (INSTRUCT). J Stroke Cerebrovasc Dis. 2022;31(1):106201. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106201 .
Hop JW, Rinkel GJ, Algra A, van Gijn J. Case-fatality rates and functional outcome after subarachnoid hemorrhage: a systematic review. Stroke. 1997;28(3):660–4. https://doi.org/10.1161/01.str.28.3.660 .
Dorsch N. A clinical review of cerebral vasospasm and delayed ischaemia following aneurysm rupture. Acta neurochirurgica Supplement. 2011;110(Pt 1):5–6. https://doi.org/10.1007/978-3-7091-0353-1_1 .
Diringer MN, Bleck TP, Hemphill CJ 3rd, Menon D, Shutter L, Vespa P, et al. Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15(2):211–40. https://doi.org/10.1007/s12028-011-9605-9 .
doi: 10.1007/s12028-011-9605-9
pubmed: 21773873
Macdonald RL. Delayed neurological deterioration after subarachnoid haemorrhage. Nat Rev Neurol. 2014;10(1):44–58. https://doi.org/10.1038/nrneurol.2013.246 .
doi: 10.1038/nrneurol.2013.246
pubmed: 24323051
Velat GJ, Kimball MM, Mocco JD, Hoh BL. Vasospasm after aneurysmal subarachnoid hemorrhage: review of randomized controlled trials and meta-analyses in the literature. World Neurosurg. 2011;76(5):446–54. https://doi.org/10.1016/j.wneu.2011.02.030 .
doi: 10.1016/j.wneu.2011.02.030
pubmed: 22152574
Petruk KC, West M, Mohr G, Weir BK, Benoit BG, Gentili F et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988;68(4):505–17. https://doi.org/10.3171/jns.1988.68.4.0505 .
Guenego A, Fahed R, Rouchaud A, Walker G, Faizy TD, Sporns PB, et al. Diagnosis and endovascular management of vasospasm after aneurysmal subarachnoid hemorrhage—survey of real-life practices. J Neurointerv Surg. 2023; https://doi.org/10.1136/jnis-2023-020544 .
doi: 10.1136/jnis-2023-020544
pubmed: 37500477
Hollingworth M, Chen PR, Goddard AJ, Coulthard A, Soderman M, Bulsara KR. Results of an International Survey on the Investigation and Endovascular Management of Cerebral Vasospasm and Delayed Cerebral Ischemia. World Neurosurg. 2015;83(6):1120–6 e1. https://doi.org/10.1016/j.wneu.2015.01.036 .
Bulsara KR, Gunel M, Amin-Hanjani S, Chen PR, Connolly ES, Friedlander RM. Results of a national cerebrovascular neurosurgery survey on the management of cerebral vasospasm/delayed cerebral ischemia. J Neurointerv Surg. 2015;7(6):408–11. https://doi.org/10.1136/neurintsurg-2014-011223 .
doi: 10.1136/neurintsurg-2014-011223
pubmed: 24811742
Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. 2018 Guidelines for the Early Management of Patients With Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2018;49(3):e46–e110. https://doi.org/10.1161/STR.0000000000000158 .
doi: 10.1161/STR.0000000000000158
pubmed: 29367334
Fragata I, Canto-Moreira N, Canhao P. Comparison of cerebral perfusion in perimesencephalic subarachnoid hemorrhage and aneurysmal subarachnoid hemorrhage. Neuroradiology. 2018;60(6):609–16. https://doi.org/10.1007/s00234-018-1997-1 .
doi: 10.1007/s00234-018-1997-1
pubmed: 29523945
Vagal A, Wintermark M, Nael K, Bivard A, Parsons M, Grossman AW et al. Automated CT perfusion imaging for acute ischemic stroke: Pearls and pitfalls for real-world use. Neurology. 2019;93(20):888–98. https://doi.org/10.1212/WNL.0000000000008481 .
van der Hoeven EJ, Dankbaar JW, Algra A, Vos JA, Niesten JM, van Seeters T, et al. Additional diagnostic value of computed tomography perfusion for detection of acute ischemic stroke in the posterior circulation. Stroke. 2015;46(4):1113–5. https://doi.org/10.1161/STROKEAHA.115.008718 .
doi: 10.1161/STROKEAHA.115.008718
pubmed: 25744516
Connolly ES, Jr., Rabinstein AA, Carhuapoma JR, Derdeyn CP, Dion J, Higashida RT et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association. Stroke. 2012;43(6):1711–37. https://doi.org/10.1161/STR.0b013e3182587839 .
Cho WS, Kim JE, Park SQ, Ko JK, Kim DW, Park JC, et al. Korean Clinical Practice Guidelines for Aneurysmal Subarachnoid Hemorrhage. J Korean Neurosurg Soc. 2018;61(2):127–66. https://doi.org/10.3340/jkns.2017.0404.005 .
doi: 10.3340/jkns.2017.0404.005
pubmed: 29526058
pmcid: 5853198
Hoh BL, Ko NU, Amin-Hanjani S, Hsiang-Yi Chou S, Cruz-Flores S, Dangayach NS, et al. Guideline for the Management of Patients With Aneurysmal Subarachnoid Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2023; https://doi.org/10.1161/STR.0000000000000436 .
doi: 10.1161/STR.0000000000000436
pubmed: 38011232
Neumann A, Kuchler J, Ditz C, Krajewski K, Leppert J, Schramm P, et al. Non-compliant and compliant balloons for endovascular rescue therapy of cerebral vasospasm after spontaneous subarachnoid haemorrhage: experiences of a single-centre institution with radiological follow-up of the treated vessel segments. Stroke Vasc Neurol. 2021;6(1):16–24. https://doi.org/10.1136/svn-2020-000410 .
doi: 10.1136/svn-2020-000410
pubmed: 32709603
Adami D, Berkefeld J, Platz J, Konczalla J, Pfeilschifter W, Weidauer S, et al. Complication rate of intraarterial treatment of severe cerebral vasospasm after subarachnoid hemorrhage with nimodipine and percutaneous transluminal balloon angioplasty: Worth the risk? J Neuroradiol. 2019;46(1):15–24. https://doi.org/10.1016/j.neurad.2018.04.001 .
doi: 10.1016/j.neurad.2018.04.001
pubmed: 29733918
Jabbarli R, Pierscianek D, Rolz R, Darkwah Oppong M, Kaier K, Shah M et al. Endovascular treatment of cerebral vasospasm after subarachnoid hemorrhage: More is more. Neurology. 2019;93(5):e458–e66. https://doi.org/10.1212/WNL.0000000000007862 .
Chen CT, Chen CC, Wang AY, Wu YM, Chin SC, Hsieh PC, et al. Early strategy of scepter XC balloon angioplasty and simultaneous Nimodipine infusion for vasospasm following ruptured aneurysm. BMC Neurol. 2020;20(1):271. https://doi.org/10.1186/s12883-020-01856-4 .
doi: 10.1186/s12883-020-01856-4
pubmed: 32635892
pmcid: 7339531
Labeyrie MA, Gaugain S, Boulouis G, Zetchi A, Brami J, Saint-Maurice JP, et al. Distal Balloon Angioplasty of Cerebral Vasospasm Decreases the Risk of Delayed Cerebral Infarction. Ajnr Am J Neuroradiol. 2019;40(8):1342–8. https://doi.org/10.3174/ajnr.A6124 .
doi: 10.3174/ajnr.A6124
pubmed: 31320465
pmcid: 7048486
Schacht H, Kuchler J, Boppel T, Leppert J, Ditz C, Schramm P, et al. Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: A single-center experience. Clin Neurol Neurosurg. 2020;188:105590. https://doi.org/10.1016/j.clineuro.2019.105590 .
doi: 10.1016/j.clineuro.2019.105590
pubmed: 31759310
Samagh N, Bhagat H, Jangra K. Monitoring cerebral vasospasm: How much can we rely on transcranial Doppler. J Anaesthesiol Clin Pharmacol. 2019;35(1):12–8. https://doi.org/10.4103/joacp.JOACP_192_17 .
doi: 10.4103/joacp.JOACP_192_17
pubmed: 31057233
pmcid: 6495622
Janjua N, Mayer SA. Cerebral vasospasm after subarachnoid hemorrhage. Curr Opin Crit Care. 2003;9(2):113–9. https://doi.org/10.1097/00075198-200304000-00006 .
doi: 10.1097/00075198-200304000-00006
pubmed: 12657973
Aldakkan A, Mansouri A, Jaja BN, Alotaibi NM, Macdonald RL, Subarachnoid Hemorrhage International Trialists C.. Predictors of Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage with Asymptomatic Angiographic Vasospasm on Admission. World Neurosurg. 2017;97:199–204. https://doi.org/10.1016/j.wneu.2016.09.096 .
doi: 10.1016/j.wneu.2016.09.096
pubmed: 27717776
Rowland MJ, Hadjipavlou G, Kelly M, Westbrook J, Pattinson KT. Delayed cerebral ischaemia after subarachnoid haemorrhage: looking beyond vasospasm. Br J Anaesth. 2012;109(3):315–29. https://doi.org/10.1093/bja/aes264 .
Keyrouz SG, Diringer MN. Clinical review: Prevention and therapy of vasospasm in subarachnoid hemorrhage. Crit Care. 2007;11(4):220. https://doi.org/10.1186/cc5958 .
doi: 10.1186/cc5958
pubmed: 17705883
pmcid: 2206512
Pickard JD, Murray GD, Illingworth R, Shaw MD, Teasdale GM, Foy PM et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid haemorrhage: British aneurysm nimodipine trial. BMJ (Clinical research ed). 1989;298(6674):636–42. https://doi.org/10.1136/bmj.298.6674.636 .
Kassell NF, Torner JC, Jane JA, Haley EC, Jr., Adams HP. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 2: Surgical results. J Neurosurg. 1990;73(1):37–47. https://doi.org/10.3171/jns.1990.73.1.0037 .